4.7 Review

Prostaglandins in asthma and allergic diseases

Journal

PHARMACOLOGY & THERAPEUTICS
Volume 193, Issue -, Pages 1-19

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pharmthera.2018.08.001

Keywords

Prostaglandin; Cyclooxygenase; Lung; Allergy; Asthma

Funding

  1. National Institutes of Health [U19 AI095227, R01 AI 124456, R01 AI 111820]
  2. Veteran Affairs Grant [I01 BX000624]

Ask authors/readers for more resources

Prostaglandins are synthesized through the metabolism of arachidonic acid via the cyclooxygenase pathway. There are five primary prostaglandins, PGD(2), PGE(2,) PGF(2), PGI(2), and thromboxane B-2, that all signal through distinct seven transmembrane, G-protein coupled receptors. The receptors through which the prostaglandins signal determines their immunologic or physiologic effects. For instance, the same prostaglandin may have opposing properties, dependent upon the signaling pathways activated. In this article, we will detail how inhibition of cyclooxygenase metabolism and regulation of prostaglandin signaling regulates allergic airway inflammation and asthma physiology. Possible prostaglandin therapeutic targets for allergic lung inflammation and asthma will also be reviewed, as informed by human studies, basic science, and animal models. (C) 2018 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available